📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice. (2018)

First Author: Tinklenberg JA

Attributed to: Determining how mutations in actin lead to skeletal muscle weakness funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddx431

PubMed Identifier: 29293963

Publication URI: http://europepmc.org/abstract/MED/29293963

Type: Journal Article/Review

Volume: 27

Parent Publication: Human molecular genetics

Issue: 4

ISSN: 0964-6906